Boyu Capital logo

Boyu Capital

Asia, Beijing, China, Beijing

Description

Boyu Capital is a prominent private equity firm based in Beijing, China, established in 2010. The firm focuses on growth capital and buyout investments, primarily targeting market-leading companies within China's dynamic economy. Its investment strategy spans critical sectors including consumer, retail, media and technology, healthcare, and financial services, reflecting a broad yet strategic approach to capturing value in high-growth industries. Boyu Capital is known for its deep local insights and strong relationships, which enable it to access proprietary deal flow and navigate the complexities of the Chinese market.

The firm typically invests in mature, well-established companies that demonstrate significant growth potential or are ripe for strategic restructuring. Boyu Capital's investments are substantial, reflecting its focus on acquiring significant minority stakes or even control positions. For instance, the firm successfully closed its fourth USD-denominated fund, Boyu Capital Fund IV, at approximately $3.2 billion in 2021, underscoring its considerable financial firepower. This scale allows Boyu to participate in large-cap transactions, often involving leading players in their respective industries.

Given its fund sizes and investment strategy, Boyu Capital's typical first cheque sizes are substantial, generally ranging from $50 million up to $500 million, depending on the deal structure and the target company's valuation. The firm has been a key investor in some of China's most iconic companies, including stakes in Alibaba's Cainiao logistics unit and Ant Group, as well as investments in healthcare giants like WuXi AppTec. These investments highlight Boyu Capital's preference for companies with strong market positions and the potential for significant long-term value creation through operational improvements and strategic expansion. The firm's total assets under management are estimated to be well over $10 billion across its various funds, solidifying its position as a major player in the Asian private equity landscape.

Investor Profile

Boyu Capital has backed more than 37 startups, with 5 new investments in the last 12 months alone. The firm has led 8 rounds, about 22% of its total and boasts 19 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, Hong Kong.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Typical check size: $50M – $500M.

Stage Focus

  • Series A (30%)
  • Series B (14%)
  • Series C (14%)
  • Series D (11%)
  • Private Equity (11%)
  • Series Unknown (8%)
  • Series E (3%)
  • Series F (3%)
  • Post Ipo Equity (3%)
  • Secondary Market (3%)

Country Focus

  • China (62%)
  • United States (27%)
  • Hong Kong (5%)
  • Indonesia (3%)
  • Singapore (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Biopharma
  • E-commerce
  • Medical
  • Artificial Intelligence (Ai)
  • Software
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Boyu Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 5
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 13
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 5
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 5
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 11
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 4
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 3
HOPU Investment Management Company
Asia, Hebei, China, Xicheng
Co-Investments: 3
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 7
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4

Which angels does Boyu Capital often collaborate with?

Shared Deals: 1

What are some of recent deals done by Boyu Capital?

Ouro Medicines

San Francisco, California, United States

Ouroboros Medicines is a biotechnology company specializes in immunology.

BiotechnologyHealth CareMedical
Series AJan 10, 2025
Amount Raised: $120,000,000
Timberlyne Therapeutics

San Diego, California, United States

Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.

BiopharmaBiotechnologyHealth Care
Series AJan 9, 2025
Amount Raised: $180,000,000
Seek Pet Foods

Shandong, Fujian, China

Seek Pet Foods is a OEM/ODM manufacturer of pet food and other products.

Food ProcessingIndustrial ManufacturingPet
Private EquityAug 12, 2024
Amount Raised: $139,372,822
Shuaike Pet Food Products

Linyi, Shandong, China

Shuaike Pet Food Products is a pet food manufacturing company.

Animal FeedFood ProcessingManufacturingPet
Series UnknownAug 8, 2024
Amount Raised: $139,380,593
Positive Sequence Biology

Shanghai, Shanghai, China

Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

BiopharmaBiotechnologyGenetics
Series AAug 8, 2024
Amount Raised: $13,938,059
Xiaohongshu

Shanghai, Shanghai, China

Xiaohongshu is a social e-commerce platform for users to share product reviews and shopping experiences.

E-CommerceMobile AppsShoppingSocial
Secondary MarketJul 11, 2024
Global Data Solutions

Shanghai, Shanghai, China

Global Data Solutions designs, builds, and operates data centers in the People's Republic of China together with its subsidiaries.

Data CenterInformation TechnologyPrivate Social NetworkingSoftware
Post Ipo EquityMar 26, 2024
Amount Raised: $587,000,000
ArriVent Biopharma

Pennsylvania Furnace, Pennsylvania, United States

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

BiotechnologyLife SciencePharmaceutical
Series BDec 29, 2022
Amount Raised: $155,000,000
Animoca Brands

Cyberport, Hong Kong Island, Hong Kong

Animoca Brands is a metaverse and gaming company focused on driving digital property rights through NFTs.

AppsBlockchainCasual GamesDeveloper PlatformMetaverseVideo Games
Private EquitySep 8, 2022
Amount Raised: $110,000,000
Frontera Therapeutics

Bedford, Massachusetts, United States

Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.

Biotechnology
Series BJun 24, 2022
Amount Raised: $160,000,000